TABLE 2:
DISTRIBUTION OF DEMOGRAPHIC CHARACTERISTICS, BY TARGET POPULATION
| Category | Overall Sample % (95% C.I.) (n = 4,961) |
High blood pressure % (95% C.I.) (n = 2,942) |
No high blood pressure % (95% C.I.) (n = 2,019) |
|
|---|---|---|---|---|
| Age | Mean: | 46.9 (46.3, 47.6) |
58.7 (57.9, 59.4) |
42.4 (41.6, 43.2) |
| 18–24 | 8.5% (7.3, 9.9) |
.4% (0.2, 1.1) |
11.6% (9.9, 13.5) |
|
| 25–34 | 16.6% (15.0, 18.4) |
3.9% (2.7, 5.7) |
21.5% (19.3, 23.8) |
|
| 35–44 | 22.6% (20.8, 24.5) |
10.9% (9.3, 12.9) |
27.1% (24.7, 29.6) |
|
| 45–54 | 19.3% (17.7, 21.0) |
19.7% (17.6, 22.0) |
19.1% (17.1, 21.4) |
|
| 55–64 | 16.5% (15.1, 17.9) |
30.9% (28.5, 33.3) |
10.9% (9.4, 12.6) |
|
| 65 or older | 16.5% (15.2, 17.9) |
34.2% (31.7, 36.7) |
9.8% (8.3, 11.4) |
|
|
| ||||
| Race/Ethnicity | White, non-Hispanic | 69.7% (67.5, 71.7) |
73.9% (71.2, 76.4) |
68.0% (65.3, 70.7) |
| Black, non-Hispanic | 11.2% (9.8, 12.8) |
13.6% (11.6, 15.8) |
10.3% (8.5, 12.5) |
|
| Hispanic | 13.4% (11.7, 15.2) |
9.0% (7.2, 11.2) |
15.0% (12.9, 17.4) |
|
| Other, non-Hispanic | 5.8% (4.9, 6.8) |
3.6% (2.8, 4.5) |
6.6% (5.4, 8.0) |
|
|
| ||||
| Gender | Male | 48.5% (46.5, 50.6) |
49.3% (46.6, 52.0) |
48.3% (45.6, 51.0) |
| Female | 51.5% (49.4, 53.5) |
50.7% (48.0, 53.4) |
51.8% (49.1, 54.5) |
|
|
| ||||
| Highest level of education | Some high school | 6.7% (5.6, 8.0) |
6.6% (5.1, 8.5) |
6.8% (5.4, 8.5) |
| High school graduate | 36.9% (34.8, 39.0) |
39.3% (36.6, 42.1) |
35.9% (33.3, 38.7) |
|
| Some college | 28.5% (26.8, 30.4) |
29.3% (27.1, 31.7) |
28.2% (26.0, 30.6) |
|
| Bachelor’s or higher | 27.9% (26.2, 29.7) |
24.8% (23.0, 26.8) |
29.1% (26.8, 31.4) |
|
|
| ||||
| Currently taking prescription drug(s) for high blood pressure | Yes, taking prescription drug | 24.5% (23.1, 25.9) |
80.9% (78.1, 83.4) |
2.9%a (2.3, 3.6) |
| No, not taking prescription drug | 75.1% (73.7, 76.5) |
18.6% (16.1, 21.4) |
96.8% (96.0, 97.5) |
|
| Refused | .4% (.2, .7) |
.5% (.3, .9) |
.3% (.1, .9) |
|
Note: C.I. = confidence interval
a
This discrepancy may be due to the fact that high blood pressure status was measured at an earlier time than prescription drug status.